340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

CMS Reviewing Comments on Medicaid Drug Pricing Proposed Rule

Providers and drug manufacturers weigh in on 340B-specific issues
 

Print Article

May 22, 2012—Regulations implementing health care reform’s Medicaid drug rebate provisions should encourage “shared savings” arrangements between 340B covered entities and Medicaid agencies, provider groups urged in comments filed with the Centers for Medicare and Medicaid Services (CMS).

Drug manufacturers, meanwhile, asked CMS to exempt any prices charged to 340B covered entities from their Medicaid best price computations as well as any 340B sales to covered entities that do not abide by program requirements.  


You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register.    Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

 

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health